(Q45768761)

English

Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group

scientific article published in March 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

1 reference

based on heuristic

inferred from title

author name string

Moler FW

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Steinhart CM

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Ohmit SE

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Stidham GL

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

language of work or name

0 references

publication date

1 March 1996

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

128

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

422-428

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Ribavirin. Ambivalence about an antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Ribavirin in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Respiratory failure and mechanical ventilation in severe bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Management of respiratory failure in infants with acute viral bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Intensive care course and outcome of patients infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Improving the outcome and efficiency of intensive care: the impact of an intensivist

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Ribavirin aerosol for acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Inhalation provocation tests using nonisotonic aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

An additional basic science for clinical medicine: II. The limitations of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970294-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(96)70294-9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8774517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45768761&oldid=2082040831"